Advertisement

What is secukinumab?

Donna Hill Howes, RN
Family Practitioner

Secukinumab (Cosentyx) blocks certain immune system proteins (IL-17A) that cause inflammation in people with psoriasis and psoriatic arthritis. It is FDA-approved for treating both conditions. For most people with psoriatic arthritis, it is given as weekly injections for 4 weeks, then given monthly. The shots can be given by a doctor, or people can give them to themselves. 

This answer was adapted from Sharecare's award-winning AskMD app. Start a consultation now to find out what's causing your symptoms, learn how to manage a condition, or find a doctor. 

Continue Learning about Plaque Psoriasis

The Connection Between Psoriatic Arthritis and Psoriasis
The Connection Between Psoriatic Arthritis and Psoriasis
Psoriatic arthritis is a type of arthritis that can develop in people that have psoriasis. In this video, Jennifer Caudle, DO, explains the relationsh...
Read More
What side effects do IL-17 inhibitors have?
Donna Hill Howes, RNDonna Hill Howes, RN
Side effects of secukinumab may include infections, a runny or stuffy nose, and diarrhea. Serious si...
More Answers
6 Psoriasis Self-Care Tips You Should Try
6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try
Find out how you can manage your psoriasis on a daily basis.
Start Slideshow
What Else Can I Do to Manage My Psoriatic Arthritis?
What Else Can I Do to Manage My Psoriatic Arthritis?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.